Age-dependent effects of diabetes and obesity on liver-related events in non-alcoholic fatty liver disease: Subanalysis of CLIONE in Asia

被引:3
作者
Seko, Yuya [1 ]
Kawanaka, Miwa [14 ]
Fujii, Hideki [2 ]
Iwaki, Michihiro [3 ]
Hayashi, Hideki [4 ]
Toyoda, Hidenori [5 ]
Oeda, Satoshi [6 ,7 ]
Hyogo, Hideyuki [9 ,15 ]
Morishita, Asahiro [16 ]
Munekage, Kensuke [10 ]
Kawata, Kazuhito [18 ]
Yamamura, Sakura [11 ]
Sawada, Koji [12 ]
Maeshiro, Tatsuji [19 ]
Tobita, Hiroshi [21 ]
Yoshida, Yuichi [22 ]
Naito, Masafumi [22 ]
Araki, Asuka [21 ]
Arakaki, Shingo [19 ]
Kawaguchi, Takumi [11 ]
Noritake, Hidenao [18 ]
Ono, Masafumi [17 ]
Masaki, Tsutomu [16 ]
Yasuda, Satoshi [5 ]
Tomita, Eiichi [4 ]
Yoneda, Masato [3 ]
Tokushige, Akihiro [13 ]
Kamada, Yoshihiro [23 ]
Takahashi, Hirokazu [6 ]
Ueda, Shinichiro [20 ]
Aishima, Shinichi [8 ]
Sumida, Yoshio [25 ]
Okanoue, Takeshi [24 ]
Itoh, Yoshito [1 ]
Nakajima, Atsushi [3 ]
机构
[1] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Gastroenterol & Hepatol, Kyoto, Japan
[2] Osaka Metropolitan Univ, Dept Hepatol, Osaka, Japan
[3] Yokohama City Univ, Div Gastroenterol & Hepatol, Grad Sch Med, Yokohama, Kanagawa, Japan
[4] Gifu Municipal Hosp, Dept Gastroenterol & Hepatol, Gifu, Japan
[5] Ogaki Municipal Hosp, Dept Gastroenterol, Ogaki, Japan
[6] Saga Univ Hosp, Liver Ctr, Saga, Japan
[7] Saga Univ Hosp, Dept Lab Med, Saga, Japan
[8] Saga Univ, Fac Med, Dept Pathol & Microbiol, Saga, Japan
[9] Life Care Clin Hiroshima, Hiroshima, Japan
[10] Kochi Med Sch, Dept Gastroenterol & Hepatol, Kochi, Japan
[11] Kurume Univ, Dept Med, Div Gastroenterol, Sch Med, Kurume, Fukuoka, Japan
[12] Asahikawa Med Univ, Dept Med, Div Metab & Biosyst Sci Gastroenterol & Hematol O, Asahikawa, Hokkaido, Japan
[13] Kagoshima Univ, Dept Cardiovasc Med & Hypertens, Grad Sch Med & Dent Sci, Kagoshima, Japan
[14] Kawasaki Med Ctr, Kawasaki Med Sch, Dept Gen Internal Med 2, Okayama, Japan
[15] JA Hiroshima Kouseiren Gen Hosp, Dept Gastroenterol, Hatsukaichi, Hiroshima, Japan
[16] Kagawa Univ, Dept Gastroenterol & Neurol, Fac Med, Takamatsu, Kagawa, Japan
[17] Kagawa Univ, Fac Med, Div Innovat Med Hepatobiliary & Pancreatol, Takamatsu, Kagawa, Japan
[18] Hamamatsu Univ, Dept Internal Med 2, Hepatol Div, Sch Med, Shizuoka, Japan
[19] Univ Ryukyus, Dept Internal Med 1, Univ Ryukyus Hosp, Nishihara, Okinawa, Japan
[20] Univ Ryukyus, Grad Sch Med, Dept Clin Pharmacol & Therapeut, Nishihara, Okinawa, Japan
[21] Shimane Univ Hosp, Div Pathol, Izumo, Shimane, Japan
[22] Osaka Univ, Suita Municipal Hosp, Dept Gastroenterol & Hepatol, Osaka, Japan
[23] Osaka Univ, Grad Sch Med, Dept Adv Metab Hepatol, Osaka, Japan
[24] Saiseikai Suita Hosp, Hepatol Ctr, Suita, Osaka, Japan
[25] Aichi Med Univ, Dept Internal Med, Div Hepatol & Pancreatol, Nagakute, Aichi, Japan
关键词
age; BMI; CLIONE in Asia; fibrosis; hepatocellular carcinoma; liver-related events; non-alcoholic fatty liver disease; non-alcoholic steatohepatitis; obesity; type 2 diabetes mellitus; FIBROSIS STAGE; RISK; CANCER; METAANALYSIS; ASSOCIATION; MORTALITY; OUTCOMES;
D O I
10.1111/jgh.16019
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aim Older age, type 2 diabetes mellitus (T2DM), and obesity are known risk factors for liver-related events (LREs). We investigated the impacts of T2DM and obesity on LRE according to age in Japanese patients with non-alcoholic fatty liver disease (NAFLD). Methods We performed a subanalysis of a retrospective cohort study (CLIONE in Asia), including 1395 patients with biopsy-proven NAFLD. The median follow-up was 4.6 years. Results The median age was 57 years, and 36.2% had T2DM. The median body mass index (BMI) was 27.4, and 28.5% were severely obese (BMI >= 30). During follow-up, 37 patients developed hepatocellular carcinoma (HCC), and 58 patients developed LRE. In patients younger than 65 years, advanced fibrosis (hazard ratio [HR] 7.69, P < 0.001) and T2DM (HR 3.37, P = 0.017) were HCC risk factors, and advanced fibrosis (HR 9.40, P < 0.001) and T2DM (HR 2.51, P = 0.016) were LRE risk factors. In patients 65 years and older, advanced fibrosis (HR 4.24, P = 0.010) and obesity (HR 4.60, P = 0.006) were HCC risk factors, and advanced fibrosis (HR 4.22, P = 0.002) and obesity (HR 4.22, P = 0.002) were LRE risk factors. Conclusion Type 2 diabetes mellitus and obesity contributed to LRE in younger and older patients, respectively, along with advanced fibrosis. Therefore, controlling T2DM in patients younger than 65 years and controlling weight in patients 65 years and older could prevent LRE. The development of age-dependent screening and management strategies is necessary for patients with NAFLD.
引用
收藏
页码:2313 / 2320
页数:8
相关论文
共 27 条
  • [1] Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
    Angulo, Paul
    Kleiner, David E.
    Dam-Larsen, Sanne
    Adams, Leon A.
    Bjornsson, Einar S.
    Charatcharoenwitthaya, Phunchai
    Mills, Peter R.
    Keach, Jill C.
    Lafferty, Heather D.
    Stahler, Alisha
    Haflidadottir, Svanhildur
    Bendtsen, Flemming
    [J]. GASTROENTEROLOGY, 2015, 149 (02) : 389 - +
  • [2] The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
    Chalasani, Naga
    Younossi, Zobair
    Lavine, Joel E.
    Diehl, Anna Mae
    Brunt, Elizabeth M.
    Cusi, Kenneth
    Charlton, Michael
    Sanyal, Arun J.
    [J]. HEPATOLOGY, 2012, 55 (06) : 2005 - 2023
  • [3] Excess body weight and the risk of primary liver cancer: An updated meta-analysis of prospective studies
    Chen, Yi
    Wang, Xiaolin
    Wang, Jianhua
    Yan, Zhiping
    Luo, Jianjun
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 (14) : 2137 - 2145
  • [4] The Role of Adiponectin in Cancer: A Review of Current Evidence
    Dalamaga, Maria
    Diakopoulos, Kalliope N.
    Mantzoros, Christos S.
    [J]. ENDOCRINE REVIEWS, 2012, 33 (04) : 547 - 594
  • [5] Increased Risk of Mortality by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
    Dulai, Parambir S.
    Singh, Siddharth
    Patel, Janki
    Soni, Meera
    Prokop, Larry J.
    Younossi, Zobair
    Sebastiani, Giada
    Ekstedt, Mattias
    Hagstrom, Hannes
    Nasr, Patrik
    Stal, Per
    Wong, Vincent Wai-Sun
    Kechagias, Stergios
    Hultcrantz, Rolf
    Loomba, Rohit
    [J]. HEPATOLOGY, 2017, 65 (05) : 1557 - 1565
  • [6] Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study
    Fujii, Hideki
    Iwaki, Michihiro
    Hayashi, Hideki
    Toyoda, Hidenori
    Oeda, Satoshi
    Hyogo, Hideyuki
    Kawanaka, Miwa
    Morishita, Asahiro
    Munekage, Kensuke
    Kawata, Kazuhito
    Yamamura, Sakura
    Sawada, Koji
    Maeshiro, Tatsuji
    Tobita, Hiroshi
    Yoshida, Yuichi
    Naito, Masafumi
    Araki, Asuka
    Arakaki, Shingo
    Kawaguchi, Takumi
    Noritake, Hidenao
    Ono, Masafumi
    Masaki, Tsutomu
    Yasuda, Satoshi
    Tomita, Eiichi
    Yoneda, Masato
    Kawada, Norifumi
    Tokushige, Akihiro
    Kamada, Yoshihiro
    Takahashi, Hirokazu
    Ueda, Shinichiro
    Aishima, Shinichi
    Sumida, Yoshio
    Nakajima, Atsushi
    Okanoue, Takeshi
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (02) : 370 - 379
  • [7] Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD
    Hagstrom, Hannes
    Nasr, Patrik
    Ekstedt, Mattias
    Hammar, Ulf
    Stal, Per
    Hultcrantz, Rolf
    Kechagias, Stergios
    [J]. JOURNAL OF HEPATOLOGY, 2017, 67 (06) : 1265 - 1273
  • [8] Association of Diabetes Duration and Diabetes Treatment With the Risk of Hepatocellular Carcinoma
    Hassan, Manal M.
    Curley, Steven A.
    Li, Donghui
    Kaseb, Ahmed
    Davila, Marta
    Abdalla, Eddie K.
    Javle, Milind
    Moghazy, Dalia M.
    Lozano, Richard D.
    Abbruzzese, James L.
    Vauthey, Jean-Nicolas
    [J]. CANCER, 2010, 116 (08) : 1938 - 1946
  • [9] The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995-2040
    Ito, Takanori
    Ishigami, Masatoshi
    Zou, Biyao
    Tanaka, Taku
    Takahashi, Hirokazu
    Kurosaki, Masayuki
    Maeda, Mayumi
    Thin, Khin Naing
    Tanaka, Kenichi
    Takahashi, Yuka
    Itoh, Yoshito
    Oniki, Kentaro
    Seko, Yuya
    Saruwatari, Junji
    Kawanaka, Miwa
    Atsukawa, Masanori
    Hyogo, Hideyuki
    Ono, Masafumi
    Ogawa, Eiichi
    Barnett, Scott D.
    Stave, Christopher D.
    Cheung, Ramsey C.
    Fujishiro, Mitsuhiro
    Eguchi, Yuichiro
    Toyoda, Hidenori
    Nguyen, Mindie H.
    [J]. HEPATOLOGY INTERNATIONAL, 2021, 15 (02) : 366 - 379
  • [10] Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease
    Kanwal, Fasiha
    Kramer, Jennifer R.
    Li, Liang
    Dai, Jianliang
    Natarajan, Yamini
    Yu, Xian
    Asch, Steven M.
    El-Serag, Hashem B.
    [J]. HEPATOLOGY, 2020, 71 (03) : 808 - 819